Crinetics Pharmaceuticals, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
Crinetics Pharmaceuticals, Inc. (CRNX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount of $4.21 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther · last filed 2026-02-26
- Crinetics Pharmaceuticals, Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2025 was $4.21M, a 69.20% increase from fiscal 2024.
- Crinetics Pharmaceuticals, Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2024 was $2.49M, a 1389.22% increase from fiscal 2023.
- Crinetics Pharmaceuticals, Inc. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2023 was $167.00K.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month |
|---|---|
| 2025-12-31 | $4.21M 10-K · filed 2026-02-26 |
| 2024-12-31 | $2.49M 10-K · filed 2026-02-26 |
| 2023-12-31 | $167.00K 10-K · filed 2026-02-26 |